Therapeutic antibodies for treating liver fibrosis
Ended Project Grant Awarded Last action
- Award ID
- R43DK125191
- Recipient
-
Abalone Bio, Inc. UEI KKSHAJA41B56
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $349,013
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $349,013 | |
| Amendment | $349,013 | |
| Amendment | $349,013 | |
| Amendment | -$349,013 | |
| Amendment | -$349,013 | |
| Amendment | -$349,013 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $349,013 |
Show all 13
Quick answers
Who received award R43DK125191?
R43DK125191 was awarded to Abalone Bio, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 1, 2020.
How much is award R43DK125191 worth?
$349,013 has been obligated on R43DK125191.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award